+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Global Low-Pressure Liquid Chromatography Market Size was valued at USD 5.4 Billion in 2022. The Low-Pressure Liquid Chromatography market industry is projected to grow from USD 5.6 Billion in 2023 to USD 10.7 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.50% during the forecast period (2023 - 2032). Increased use of cutting-edge technology in clinical laboratories and the use of protein-based vaccinations, are the key market drivers enhancing the market growth.
Download Free Sample to learn more about this report
Component: Secondary Research, Primary Research, Research Layer Database and Analyst Review
Rising investments in pharmaceutical development, an increase in R&D facilities, modernisation of lab facilities, and favourable government regulatory requirements are driving the market for low-pressure liquid chromatography. Market participants also take part in commercial endeavours, the introduction of new goods and services, service contracts, and connections with both public and private research institutions. With increased government funding for research infrastructure, it is projected that the market for low-pressure liquid chromatography would grow over time. Government organisations in countries including the US, India, China, and Japan are modernising and technologically advancing the infrastructure for clinical research and medicine creation. These components are the low-pressure liquid chromatography market catalysts, and growth in their use is projected during the forecast period.
Although they are still in the early stages of clinical development, protein-based vaccines show enormous potential as therapeutics. The growing interest in the creation of vaccines based on peptides is driving the market for low-pressure liquid chromatography. The peptide-based drugs are cost-effective, safe, and effective. Pharmaceutical companies are also developing therapies for acellular pertussis and hepatitis-B using protein subunits. Additionally, researchers from all around the world were keen to develop protein-based subunit vaccines during the COVID-19 pandemic. In November 2020, researchers from the UK developed a protein-based vaccine to treat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These shots will eventually take the place of current mRNA-based shots. The COVID-19 recombinant protein vaccine is being made by companies like Sanofi (France) and GSK (UK). The business announced in May 2021 that the third phase of the clinical study for the COVID-19 recombinant vaccine would start. Business expects to receive vaccination approval by the fourth quarter of 2021 after reviewing the results of prior clinical tests for the recombinant protein vaccine. Over the expected period, it is anticipated that the development of such a cutting-edge vaccination would drive the market for low-pressure liquid chromatography to grow.
As more people become aware of this method, government organisations in the United States, Europe, and Asia Pacific continue to invest in and provide grants and funding for the development of liquid chromatography. This will increase the potential for new chromatographic technologies to be developed, which will encourage the growth of the liquid chromatography market globally. The government is providing more money for medical research, which is driving up demand for liquid chromatography equipment. This factor probably has an impact on the market. The rise of the global liquid chromatography market is significantly fueled by investments made in biomedical companies in the Asia Pacific region. Therefore, it is projected that increased government support and collaboration across related organisations will lead to growth in the global liquid chromatography market. The utilisation of pharmaceutical items in medication development and quality assessment is also projected to fuel market growth. Additionally, the availability of some liquid chromatography devices in labs and the growing significance of chromatography tests in the pharmaceutical approval process restrain market growth during the predicted period. The future growth rate of the liquid chromatography devices market will be positively impacted by the development of generics and CROS as well as the therapeutic conversion to novel biological entities. Thus, driving the Low-Pressure Liquid Chromatography market revenue.
The global Low-Pressure Liquid Chromatography market segmentation, based on Component, includes Instruments, Consumables, and Services. Instruments segment accounted for the largest revenue share in 2022. This particular kind of tool is utilised for accurate work. These tools are used to perform chromatographic separations. Among the instruments are items like pumps, detectors, columns, and flow cells.
The global Low-Pressure Liquid Chromatography market segmentation, based on End User, includes Pharmaceutical Companies, Biotechnology Companies, Research Laboratories, and Academic Institution. Pharmaceutical Companies segment dominated the global Low-Pressure Liquid Chromatography market in 2022. It is a specific form of firm that develops, researches, and produces both name-brand and generic medications. Pharmaceutical businesses employ low-pressure liquid chromatography equipment to create novel, tailored drugs.
Download Free Sample to learn more about this report
Component: Secondary Research, Primary Research, Research Layer Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Low-Pressure Liquid Chromatography Market dominated this market in 2022 (45.80%). increasing funding for the development of novel products based on gene therapy, increasing usage of accurate and efficient liquid chromatography, and increased investment in adeno-associated viral therapy are all responsible for this. Due to the region's expanding older population and increased demand for diagnostic testing, the market for low-pressure liquid chromatography products is also accelerating. These elements are likely to drive the low-pressure liquid chromatography market in North America. Further, the U.S. Low-Pressure Liquid Chromatography market held the largest market share, and the Canada Low-Pressure Liquid Chromatography market was the fastest growing market in the North America region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Download Free Sample to learn more about this report
Component: Secondary Research, Primary Research, Research Layer Database and Analyst Review
Europe Low-Pressure Liquid Chromatography market accounted for the healthy market share in 2022. The increasing use of gene therapy in the region is driving the market for low-pressure liquid chromatography in Europe. Further, the German Low-Pressure Liquid Chromatography market held the largest market share, and the U.K Low-Pressure Liquid Chromatography market was the fastest growing market in the European region.
The Asia Pacific Low-Pressure Liquid Chromatography market is expected to register significant growth from 2023 to 2032. This is due to the emergence of new diseases, an ageing population, increased investment in research facilities, and supporting governmental policies. These factors are expected to increase the market demand for low-pressure liquid chromatography in the predicted time frame. Additionally, it is anticipated that increased funding for ongoing clinical investigations and pharmacological development may hasten the region's sales of low-pressure liquid chromatography. Moreover, China’s Low-Pressure Liquid Chromatography market held the largest market share, and the Indian Low-Pressure Liquid Chromatography market was the fastest growing market in the Asia-Pacific region.
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Low-Pressure Liquid Chromatography market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Low-Pressure Liquid Chromatography industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Low-Pressure Liquid Chromatography industry to benefit clients and increase the market sector. In recent years, the Low-Pressure Liquid Chromatography industry has offered some of the most significant advantages to medicine. Major players in the Low-Pressure Liquid Chromatography market, including Novasep, LEWA GmbH, Biolinx Labsystems, Bio-Rad Laboratories Inc., Danaher Corporation, and Nilsan Nishotech Systems Pvt. Ltd., are attempting to increase market demand by investing in research and development operations.
Industrial, commercial, professional, and medical items and services are developed, produced, and sold by Danaher Corp. (Danaher). There are numerous testing tools, communication systems, water quality systems, medical diagnostic tools, life science research instruments, professional microscopes, product identification systems, sustainable packaging design systems, automation systems, and sensors and controls systems available. The company has sites for manufacture, sales, distribution, service, and administration across Europe, Australia, Asia, and the Americas. The company sells its goods to customers in the Americas, Europe, the Middle East, Africa, and Asia-Pacific through direct sales reps and independent distributors. The corporation has its headquarters in the US city of Washington, DC. In December 2019, Danaher Corporation (US) acquired General Electric's Healthcare Life Sciences Biopharma Business to expand its understanding of low-pressure liquid chromatography technology. The KTAprocess, a low-pressure liquid chromatography system from GE, has a feature called purification. The acquisition increased the company's product line in the low-pressure liquid chromatography industry.
Bio-Rad Laboratories, Inc. (US) is one of the leading manufacturers and suppliers of low-pressure liquid chromatography tools and supplies. For the purification of biomolecules in particular, Bio-Rad Laboratories, Inc. (US) offers the BioLogic LP low-pressure chromatography system. The device needs a smaller installation space because of its compact size. The instrument incorporates 254 and 280 nm filters for the purpose of identifying proteins and nucleic acids. The system also has a conductivity cell to monitor gradient growth. A back pressure of 30 psi is produced by the dual-channel peristaltic pump that is built into the low-pressure liquid chromatography system. A wide range of accessories are offered for sale by the business, including the BioFrac Fraction Collector, Model 2110 Fraction Collector, Econo Gradient Pump, Biologic LP Valves, and Biologic LP Data View Software.
· Novasep
· LEWA GmbH
· Biolinx Labsystems
· Bio-Rad Laboratories Inc.
· Danaher Corporation
· Nilsan Nishotech Systems Pvt. Ltd.
July 2022: Waters Corporation has declared that it will provide technology and expertise to further the study of plant-based proteins in collaboration with researchers at the Plant Protein Innovation Centre (PPIC) at the University of Minnesota. Waters experts will work with PPIC researchers to develop a system for evaluating the amino acid composition of plant-based proteins using a Waters ACQUITYTM Premier UPLC System. The PPIC is a premier interdisciplinary research institute devoted to the study of plant and alternative proteins, and Waters is the first manufacturer of analytical instruments to join.
· Instruments
· Consumables
· Services
· Pharmaceutical Companies
· Biotechnology Companies
· Research Laboratories
· Academic Institution
· North America
- US
- Canada
· Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
· Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
· Rest of the World
- Middle East
- Africa
- Latin America
Report Scope
|
Report Attribute/Metric |
Details |
|
Market Size 2022 |
USD 5.4 Billion |
|
Market Size 2023 |
USD 5.6 Billion |
|
Market Size 2032 |
USD 10.7 Billion |
|
Compound Annual Growth Rate (CAGR) |
7.50% (2023-2032) |
|
Base Year |
2022 |
|
Market Forecast Period |
2023-2032 |
|
Historical Data |
2018- 2022 |
|
Market Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
Component, End User, and Region |
|
Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
|
Countries Covered |
The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
|
Novasep, LEWA GmbH, Biolinx Labsystems, Bio-Rad Laboratories Inc., Danaher Corporation, and Nilsan Nishotech Systems Pvt. Ltd. |
|
|
Key Market Opportunities |
· Increasing investment in R&D activities |
|
Key Market Dynamics |
· Increasing prevalence of protein based vaccines and increasing integration of advanced equipment in the clinical laboratories |
The global Low-Pressure Liquid Chromatography Market was valued at USD 5.4 billion in 2022, and it is estimated to reach USD 10.7 billion by 2032.
The global market is projected to grow at a CAGR of 7.50% during the forecast period, 2023-2032.
North America had the largest share in the global market
The key players in the market are Novasep, LEWA GmbH, Biolinx Labsystems, Bio-Rad Laboratories Inc., Danaher Corporation, and Nilsan Nishotech Systems Pvt. Ltd.
The Instruments Component dominated the market in 2022.
The Pharmaceutical Companies End User had the largest share in the global market.
Report Code :
RL6545
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst